Frank Takkinen
Stock Analyst at Lake Street
(1.77)
# 3,359
Out of 5,090 analysts
69
Total ratings
33.33%
Success rate
-9.7%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Maintains: Buy | $30 → $40 | $33.32 | +20.05% | 2 | Dec 4, 2025 | |
| NOTV Inotiv | Maintains: Buy | $5 → $3 | $0.81 | +271.43% | 8 | Dec 4, 2025 | |
| ADGM Adagio Medical Holdings | Initiates: Buy | $4 | $0.93 | +331.97% | 1 | Dec 2, 2025 | |
| TELA TELA Bio | Maintains: Buy | $6 → $3 | $1.15 | +160.87% | 3 | Dec 1, 2025 | |
| LUNG Pulmonx | Maintains: Buy | $8 → $4 | $2.01 | +99.00% | 3 | Oct 28, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $7 | $8.05 | -13.04% | 6 | Oct 21, 2025 | |
| RCEL AVITA Medical | Downgrades: Hold | $8 → $4 | $3.50 | +14.29% | 1 | Oct 17, 2025 | |
| ELUT Elutia | Maintains: Buy | $8 → $6 | $0.69 | +772.73% | 4 | Sep 10, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.5 → $2 | $1.08 | +85.19% | 2 | Aug 14, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $150 | $136.81 | +9.64% | 2 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $13.47 | +78.17% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $30 | $29.38 | +2.11% | 1 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $14 | $9.05 | +54.70% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $16 → $15 | $11.20 | +33.93% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $26 | $18.28 | +42.23% | 3 | Feb 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $30 | $13.54 | +121.57% | 4 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $5 | $5.57 | -10.23% | 2 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $4.67 | +328.27% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.88 | +165.96% | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $30 | $44.59 | -32.72% | 2 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $6 | $0.84 | +612.67% | 2 | Apr 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.41 | +65.98% | 2 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $16.40 | -26.83% | 2 | Dec 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $9 | $3.94 | +128.43% | 3 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $16 | $2.40 | +566.67% | 2 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $9.23 | $0.33 | +2,705.47% | 2 | Jan 18, 2023 |
Axogen
Dec 4, 2025
Maintains: Buy
Price Target: $30 → $40
Current: $33.32
Upside: +20.05%
Inotiv
Dec 4, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $0.81
Upside: +271.43%
Adagio Medical Holdings
Dec 2, 2025
Initiates: Buy
Price Target: $4
Current: $0.93
Upside: +331.97%
TELA Bio
Dec 1, 2025
Maintains: Buy
Price Target: $6 → $3
Current: $1.15
Upside: +160.87%
Pulmonx
Oct 28, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $2.01
Upside: +99.00%
Sight Sciences
Oct 21, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $8.05
Upside: -13.04%
AVITA Medical
Oct 17, 2025
Downgrades: Hold
Price Target: $8 → $4
Current: $3.50
Upside: +14.29%
Elutia
Sep 10, 2025
Maintains: Buy
Price Target: $8 → $6
Current: $0.69
Upside: +772.73%
Hyperfine
Aug 14, 2025
Maintains: Buy
Price Target: $1.5 → $2
Current: $1.08
Upside: +85.19%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $150
Current: $136.81
Upside: +9.64%
Jul 16, 2025
Initiates: Buy
Price Target: $24
Current: $13.47
Upside: +78.17%
Jun 12, 2025
Assumes: Buy
Price Target: $30
Current: $29.38
Upside: +2.11%
Apr 8, 2025
Maintains: Buy
Price Target: $19 → $14
Current: $9.05
Upside: +54.70%
Mar 24, 2025
Downgrades: Hold
Price Target: $16 → $15
Current: $11.20
Upside: +33.93%
Feb 14, 2025
Maintains: Buy
Price Target: $17 → $26
Current: $18.28
Upside: +42.23%
Jan 21, 2025
Maintains: Buy
Price Target: $17 → $30
Current: $13.54
Upside: +121.57%
Jan 14, 2025
Maintains: Buy
Price Target: $4 → $5
Current: $5.57
Upside: -10.23%
Jan 8, 2025
Initiates: Buy
Price Target: $20
Current: $4.67
Upside: +328.27%
Dec 11, 2024
Initiates: Buy
Price Target: $5
Current: $1.88
Upside: +165.96%
Jul 2, 2024
Maintains: Buy
Price Target: $28 → $30
Current: $44.59
Upside: -32.72%
Apr 3, 2024
Maintains: Buy
Price Target: $3 → $6
Current: $0.84
Upside: +612.67%
Mar 5, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $2.41
Upside: +65.98%
Dec 27, 2023
Reiterates: Buy
Price Target: $12
Current: $16.40
Upside: -26.83%
Jun 15, 2023
Maintains: Buy
Price Target: $6 → $9
Current: $3.94
Upside: +128.43%
May 18, 2023
Maintains: Buy
Price Target: $14 → $16
Current: $2.40
Upside: +566.67%
Jan 18, 2023
Maintains: Buy
Price Target: $31 → $9.23
Current: $0.33
Upside: +2,705.47%